European Journal of Neurology

Article	Citations
	132
Clinical and Genetic Reassessment in Patients With Clinically Diagnosed Hereditary Polyneuropathy	95
	94
Out‐of‐hospital versus in‐hospital status epilepticus: The role of etiology and comorbidities	93
Prioritization process for European Academy of Neurology clinical practice guidelines	83
Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study	82
Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study	73
Switching from ligand to receptor anti‐calcitonin gene‐related peptide (CGRP) antibodies or vice versa in non‐responders: A controlled cohort study	67
Neuropathy in GAA‐FGF14 Late‐Onset Cerebellar Ataxia (SCA27B): Prevalence and Characteristics	66
Correlation between patient‐reported manual ability and three objective measures of upper limb function in people with multiple sclerosis	65
Concerns Regarding “Small Fiber Morphology and Function in Inclusion Body Myositis—A Multimodal Assessment Including Confocal Corneal Microscopy”	62
COQ2 and SNCA polymorphisms interact with environmental factors to modulate the risk of multiple system atrophy and subtype disposition	61
Response to erenumab assessed by Headache Impact Test‐6 is modulated by genetic factors and arterial hypertension: An explorative cohort study	59
The effect of influenza vaccination on the rate of dementia amongst older adults	58
Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case report	58
Issue Information	57
Structural correlations between brain magnetic resonance image‐derived phenotypes and retinal neuroanatomy	52
Central nervous system crystal‐storing histiocytosis: A case report and literature review	50
ePoster	49
Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple Sclerosis	48
Lessons from the past to understand the future	47
Diagnostic accuracy of nerve excitability and compound muscle action potential scan derived biomarkers in amyotrophic lateral sclerosis	47
CCR5‐Δ32polymorphism—a possible protective factor from gait impairment amongst post‐stroke patients	46
Risk factors, neuroimaging correlates and prognosis of the motoric cognitive risk syndrome: A population‐based comparison with mild cognitive impairment	46
Neurovascular Involvement in Fibromuscular Dysplasia: A Clue for Reappraisal of Old Classifications	45

Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients	44
Electroencephalography functional connectivity—A biomarker for painful polyneuropathy	43
Ischaemic cerebral small vessel disease caused by adenosine deaminase 2 deficiency syndrome	43
Hearing impairment and development of parkinsonism and possible rapid eye movement sleep behaviour disorder: A CLSA prospective population‐based study	41
Advancements in targeted therapies for generalized acetylcholine receptor antibody positive myasthenia gravis: Beginnings of a paradigm shift	41
Basal ganglia ischaemic infarction after thrombectomy: cognitive impairment at acute stage	41
Long‐term MRI changes in a patient with Kelch‐like protein 11‐associated paraneoplastic neurological syndrome	40
Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease	40
Comparative features and outcomes of major neurological complications of COVID‐19	40
A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis	38
The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective	38
Mindfulness or meditation therapy for Parkinson's disease: A systematic review and meta‐analysis of randomized controlled trials	38
Cost‐effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health‐related quality of life	38
Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms	37
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment	37
The microbiome–gut–brain axis in epilepsy: pharmacotherapeutic target from bench evidence for potential bedside applications	37
Issue Information	37
Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study	37
Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosis	37
Issue Information	36
	35
Peripheral neuropathy in ataxia‐telangiectasia: Newly characterized, has potential as a biomarker	34
Education for fatigue management in people with multiple sclerosis: Systematic review and meta‐analysis	34
SARS‐CoV‐2 cannot unmask Parkinson's disease if there was none before infection	34
Nonamyloidogenic TTR gene variants c.76G>A and c.337‐18G>C are not associated with idiopathic small‐fiber neuropathy	34
Ipsilateral hand impairment predicts long‐term outcome in patients with subacute stroke	34
A clinical concern: Neisseria meningitidis as a reemerging pathogen with increased antimicrobial resistance	34
Corrigendum to “Tremor After Solid Organ Transplantation: Results From the TransplantLines Biobank and Cohort Study”	33
Macroglossia: A potentially severe complication of late‐onset Pompe disease	33
Arterial Stiffness, Central Blood Pressure, and the Risk of Incident Stroke in Hypertensive Adults	33
Diverging medical and legal perceptions of the need for legal guardianship in people with dementia: A qualitative study	33
Hyperreflective retinal foci are associated with retinal degeneration after optic neuritis in neuromyelitis optica spectrum disorders and multiple sclerosis	33
Issue Information	32
A Transfer Strategy Utilizing a Helicopter and a Ground Ambulance Together Does Not Prolong Door‐In‐Door‐Out Times in Thrombectomy Patients: A Retrospective Analysis	32
Nerve Conduction Study and the Prognosis of Amyotrophic Lateral Sclerosis: Exploration of Additional Neuroelectrophysiological Parameters	32
Neurology Undergraduate Medical Education: A Scoping Review	31
Causes of hospitalization and mortality in persons with epilepsy: The EpiLink Bologna cohort, Italy	31
Hereditary Transthyretin Amyloidosis in Israel: Genetic Landscape and Clinical Characteristics	31
Treatment reduces the incidence of newly appearing multiple sclerosis lesions evolving into chronic active, slowly expanding lesions: A retrospective analysis	31
Hypersomnia in anti‐glutamic acid decarboxylase 65 (GAD65) associated neurological syndromes: A pilot study	31
Trajectories of physical activity after ischaemic stroke: Exploring prediction of change	31
First‐line steroid treatment for spontaneous intracranial hypotension	30
Alterations of Fat and Ketone Body Metabolism in ALS and SMA—A Prospective Observational Study	30
‘Positive’ inter‐ictal clinical signs of functional neurological disorders are found in patients with functional dissociative seizures	29
Focused Workshops	29
Lower initial red blood cell count in cerebrospinal fluid predicts good functional outcome in patients with spontaneous subarachnoid haemorrhage	29
IgG4‐Related Disease Associated With Myotonic Dystrophy Type 2	29
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome	28
Oral Presentations	28
Exploring the role of attention towards balance in chronic dizziness: Development of the Balance Vigilance Questionnaire	28

Dynamic Bayesian networks for stratification of disease progression in amyotrophic lateral sclerosis	28
Dehydration associates with lower urinary tract symptoms in progressive multiple sclerosis	28
Intraepineurial Fat Fraction: A Novel MR Neurography‐Based Biomarker in Transthyretin Amyloidosis Polyneuropathy	28
Contractile properties and magnetic resonance imaging‐assessed fat replacement of muscles in myotonia congenita	28
Hyponatremia is associated with unfavorable outcomes after reperfusion treatment in acute ischemic stroke	27
Myoclonus in patients with COVID‐19: Findings of autoantibodies against brain structures in cerebrospinal fluid	27
Prevalence and Spectrum of Neuropathies in a Cohort of 585 Patients With Immunoglobulin A Monoclonal Gammopathy	27
The characteristics of intracranial plaques of unilateral, anterior circulation embolic stroke of undetermined source: An analysis of different subtypes based on high‐resolution imaging	27
High‐resolution magnetic resonance imaging of acute intracranial artery thrombus	27
Issue Information	27
Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response	27
Type 2 diabetes mellitus duration and subsequent risk of Alzheimer disease	27
Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real‐world data study	26
Care in Europe after presenting to the emergency department with a seizure; position paper and insights from the European Audit of Seizure Management in Hospitals	26
Association of symptomatic atherosclerotic carotid arteries with plaque areas showing low densities on computed tomographic angiography	26
Epilepsy professionals' views on sudden unexpected death in epilepsy counselling: A tale of two countries	26
Etiologic distribution of isolated abducens nerve palsy: Analysis of 807 patients and literature review	26
Generative artificial intelligence in neurology: Opportunities and risks	26
Apolipoprotein E polymorphism ε4‐stratified longitudinal association between daytime naps, sleep apnea and mild cognitive impairment: A prospective cohort study	26
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease	26
Renal Cell Carcinoma With Unknown Primary in the Femur: The Loch Ness Monster?	26
The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis	25
Apolipoprotein E epsilon4 allele is associated with better performance language and visual memory in spinocerebellar ataxia type 3	25
Risk of Parkinson disease in stroke patients: A nationwide cohort study in South Korea	25
Can Non‐Thymomatous Late‐Onset Myasthenia Gravis Benefit From Thymectomy? A Systematic Review and Meta‐Analysis	25
Elevated Serum MCP‐2 and TARC Associated With Increased Risk of Death in Guamanian ALS Patients	24
ePresentations	24
Mutations in alpha‐B‐crystallin cause autosomal dominant axonal Charcot–Marie–Tooth disease with congenital cataracts	24
Social cognition deficits in amyotrophic lateral sclerosis: A pilot cross‐sectional population‐based study	24
Symposia	24
Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome	23
Data‐Driven Clustering Approach to Identify Different Phenotypes of Primary Central Nervous System Vasculitis	23
Cerebrotendinous xanthomatosis: A complex interplay between a clinically and genetically heterogeneous condition	23
Comparative Analysis of SiMoA and Ella Immunoassay Platforms for Measuring Serum Neurofilament Light Chain Levels in ATTRv With Polyneuropathy and Presymptomatic Carriers	23
Structural Alterations Associated With Cardiovascular Autonomic Failure in Multiple System Atrophy	23
Spinal muscular atrophy: Should we prescribe approved drugs to cohorts of patients in which they are unproven?	23
A diagnostic framework to identify vestibular involvement in multi‐sensory neurological disease	23
Association between COVID‐19 vaccination and myasthenia gravis: A population‐based, nested case–control study	22
Non‐alcoholic fatty liver disease and stroke: A Mendelian randomization study	22
Key priorities in rare neurological diseases: A statement from the Coordinating Panel on Rare Neurological Diseases of the European Academy of Neurology	22
Epilepsy Management in Transgender Population: More Research for Better Treatment	22
Use of antihypertensive medication and formation of de novo intracranial aneurysms	22
Histopathological characterization of cerebral small vessel disease in epilepsy patients with temporal lobe epilepsy submitted to surgery: A case–control study	22
Comment on “Association between depression and motoric cognitive risk syndrome among community‐dwelling older adults in China: A 4‐year prospective cohort study”	22
Association of aberrant brain network dynamics with gut microbial composition uncovers disrupted brain–gut–microbiome interactions in irritable bowel syndrome: Preliminary findings	22
Clinical presentation and neural correlates of stroke‐associated spatial delusions	22
Neurofilament light chain and profilin‐1 dynamics in 30 spinal muscular atrophy type 3 patients treated with nusinersen	22
Spontaneous intracranial hypotension — Neurological symptoms, diagnosis, and outcome	22
Letter to the Editor in response to “Hepatitis E virus and Bell’s palsy”	22
Meningoencephalitis due to Mycobacterium lentiflavum in an immunocompromised patient: Case report	22
Exercise induced muscle blood flow is decreased in Charcot–Marie–Tooth disease type 1 polyneuropathy: a power Doppler analysis	22
Development of Machine‐Learning‐Based Models for Detection of Cognitive Impairment in Patients Receiving Maintenance Hemodialysis	22
Post‐COVID‐Syndrome Patients Might Overestimate Own Cognitive Impairment	21
Issue Information	21
	21
Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis	21
Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status	21
Longitudinal analysis of anthropometric measures over 5 years in patients with Friedreich ataxia in the EFACTS natural history study	21
Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke	21
Quantitative Brain MRI Analysis in Neurodegenerative Langerhans Cell Histiocytosis	21
Brain Iron Alteration in Pediatric Tourette Syndrome: A Quantitative Susceptibility Mapping Study	21
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop)	21
Glutamine Metabolism and Metabolic Profiling Using 7 T CRT‐FID MRSI in Focal Epilepsy	20
Confirmed disability progression as a marker of permanent disability in multiple sclerosis	20
Socioeconomic status as a risk factor for motoric cognitive risk syndrome in a community‐dwelling population: A longitudinal observational study	20
HAPLN3 p.T34A contributes to incomplete penetrance of moyamoya disease in Chinese carrying RNF213 p.R4810K	20
Optimal cut‐off value of the modified Toronto Clinical Neuropathy Score in the diagnosis of polyneuropathy	20
Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis	20
Clinical and Genetic Characterization of the Largest Cohort of Patients With D3 Limb‐Girdle Muscular Dystrophy in an Isolated Uruguayan Population	20
Serum neurofilament light chain does not detect self‐reported treatment‐related fluctuations in chronic inflammatory demyelinating polyneuropathy	20
Retrograde Amnesia in LGI1 and CASPR2 Limbic Encephalitis: Two Case Reports and a Systematic Literature Review	20
Comparison between PFN1 and SOD1 mutations in amyotrophic lateral sclerosis	20
Tracking myasthenia gravis severity over time: Insights from the French health insurance claims database	20
The many faces of globular glial tauopathy: A clinical and imaging study	20
Distinctive Progression Patterns of Brain Structural Damage Aid Classification of Frontotemporal Dementia Variants	20
Migraine and atrial fibrillation: a systematic review	20
Quantitative proteomic analysis of cerebrospinal fluid from patients with idiopathic facial nerve palsy	20
Plenary Sessions	20
Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid‐refractory multiple sclerosis relapses	20
Smartphone and custom‐made software to assess the effect of botulinum toxin in essential blepharospasm: Initial results	20

Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial	20
Prospective follow‐up study of youth and adults with onset of functional tic‐like behaviours during the COVID‐19 pandemic	19
The spectrum of central nervous system involvement in Whipple's disease	19
Cardioembolic Breakthrough Stroke: When Anticoagulation Fails, Is Left Atrial Appendage Closure the Next Step?	19
New cellular imaging‐based method to distinguish the SPG4 subtype of hereditary spastic paraplegia	19
Cognitive sequelae of long COVID may not be permanent: A prospective study	19
Prolonged venous transit is associated with lower odds of excellent recovery after reperfusion in anterior large‐vessel occlusion stroke	19
Quantification of muscle involvement in familial amyloid polyneuropathy using MRI	19
Parkinson´s disease cardiovascular symptoms: A new complex functional and structural insight	19
Latency of poststroke epilepsy can predict drug resistance	19
Hormone therapy and disease activity in Danish women with multiple sclerosis: A population‐based cohort study	19
Combined Brain‐Cardiac CT in Ischemic Stroke: Unveiling Atrial Markers Linked to Large Vessel Occlusion in AF Patients	19
Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy	19
Long‐term follow‐up of 64 children with classical infantile‐onset Pompe disease since 2004: A French real‐life observational study	19
Diagnostic accuracy of nerve ultrasonography for the detection of peripheral neuropathy in type 2 diabetes	19
A fast and non‐invasive artificial intelligence olfactory‐like system that aids diagnosis of Parkinson's disease	19
Association between choroid plexus volume and cognition in Parkinson disease	19
Corrigendum	19
Analysis of individual alpha frequency in a large cohort from a tertiary memory center	18
Polygenic risk of Alzheimer's disease in the Faroe Islands	18
Quantitative magnetic resonance neurographic characterization of peripheral nerve involvement in manifest and pre‐ataxic spinocerebellar ataxia type 3	18
Issue Information	18
Cost‐effectiveness of surgical treatment compared to medical treatment in patients with drug‐refractory epilepsy: A systematic review	18
Peripherin: A Novel Early Diagnostic and Prognostic Plasmatic Biomarker in Amyotrophic Lateral Sclerosis	18
Three to four mRNA COVID‐19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralization	18
Corrigendum	18
Early infantile epileptic encephalopathy related to NECAP1: Clinical delineation of the disease and review	18
Relationship between migraine and epilepsy in a large population‐based cohort: The HUNT Study	18
Safety and Effectiveness of PCSK9 Inhibitors and Inclisiran in Patients With Neuromuscular Disorders and Statin Intolerance	18
Clinical autonomic nervous system laboratories in Europe	18
European Academy of Neurology guidance for developing and reporting clinical practice guidelines on rare neurological diseases	18
Cannabis and Cognitive Function in Multiple Sclerosis: Findings From a Large Consecutive Clinical Sample	18
The impact of hybrid immunity on immune responses after SARS‐CoV‐2 vaccination in persons with multiple sclerosis treated with disease‐modifying therapies	18
Iatrogenic systemic botulism after intragastric botulinum neurotoxin injection: Case report	18
Unraveling brain fog in post‐COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms	18
Optimizing Prehospital Acute Transfer of Patients With Presumed Stroke Given Economic Constraints	18
Decrement of choroid vascularization during spontaneous migraine attacks: An optical coherence tomography angiography study	18
Autoimmune encephalitis: Should we consider third‐line immunotherapies earlier?	18
Global Health Inequalities in the Burden of Ischemic Stroke From 1990 to 2021	17
Plenary Symposium	17
Giancarlo COMI (1947–2024)	17
Aetiology of Acute Respiratory Insufficiency in Patients With Ischaemic Stroke Studied by Chest CT Scan	17
Association of short‐term exposure to ambient air pollution with mortality from ischemic and hemorrhagic stroke	17
Lower cerebral arterial blood flow is associated with greater serum neurofilament light chain levels in multiple sclerosis patients	17
Parkinson disease following COVID‐19: Report of six cases	17
Global Temporal Trends and Projections of Stroke Among Women of Childbearing Age: An Age–Period–Cohort Analysis Based on the Global Burden of Disease Study 2021	17
History of Traumatic Brain Injury Does Not Influence Rate of Progression of Clinical or Pathological Outcomes in Two Early Parkinson's Disease Cohorts	17
Central vein sign and paramagnetic rim sign: From radiologically isolated syndrome to multiple sclerosis	17
Compassionate mind training for people with Parkinson's disease: A pilot study and predictors of response	17
Functional outcome after initial and multiple intracerebral hemorrhages in children with cerebral cavernous malformations	17
Sex differences in early‐onset Alzheimer's disease	17
Glymphatic Function in Prodromal Parkinson's Disease: Associations With Symptoms, Gray Matter Volume, and Phenoconversion Risk	17
Midline sacral meningeal cysts: Neurophysiology abnormalities and their correlation with pelvic sensory and visceral symptoms	17
Special Sessions	17
Symposia	17
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis	17
Cerebral Amyloid Angiopathy‐Related Inflammation in Iatrogenic Cerebral Amyloid Angiopathy	17
The analgesic effect of electroencephalographic neurofeedback for people with chronic pain: A systematic review and meta‐analysis	17
Diagnostic Yield of Anti‐Neuronal Antibody Testing in Patients Suspected of an Infectious Encephalitis	17
The effect of head‐down tilt in experimental acute ischemic stroke	16
Long‐Term Effectiveness of Early Versus Late Microvascular Decompression for Trigeminal Neuralgia Secondary to Arterial Compression	16
A comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody‐associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis	16
Smartphone‐derived keystroke dynamics are sensitive to relevant changes in multiple sclerosis	16
Behavioural intervention in medication overuse headache: A concealed double‐blind randomized controlled trial	16
	16
Clinical outcomes of delayed mechanical thrombectomy: Descriptive analysis and development of a screening tool	16
Clinical Findings in Temporal Lobe Epilepsy Associated With Isolated Amygdala Enlargement	16
Focused Workshops	16
Altered motor cortex physiology and dysexecutive syndrome in patients with fatigue and cognitive difficulties after mild COVID‐19	16
Expert opinions on pharmacological symptomatic treatment of behavioral symptoms in frontotemporal dementia: A survey of the Neuropsychiatric International Consortium on Frontotemporal Dementia (NIC‐FT	16
	16
GGC expansions in NOTCH2NLC contribute to Parkinson disease and dopaminergic neuron degeneration	16
A founder variant in the RYR1 gene is associated with hyperCKemia, myalgia and muscle cramps	16
Nonstenotic intracranial atherosclerosis as an emerging mechanism in cryptogenic cerebral embolism	16
Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia	16
	16
Neurological autoimmunity in patients with non‐pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles	15
Association of diabetes mellitus with dementia‐ and non‐dementia‐related mortality amongst women: a secondary competing risks analysis of the California Teachers Study	15
Split Hand Syndrome in Charcot–Marie–Tooth Disease Type X1 (CMTX1): A Clinical, Neurophysiological, and Radiological Study	15
Suicide Risk and Associated Factors in Parkinson Disease: A Nationwide Cohort Study	15
Shoulder‐Touch test to reveal incongruencies in persons with functional motor disorders	15
Migraine worsening after COVID‐19 and COVID‐19 vaccination: Are we facing a nocebo effect?	15
Thank You to Our Peer Reviewers in 2024	15
Correction to “Tirofiban Benefits the Outcome of Stroke Patients With Large Artery Atherosclerosis Achieving Full Reperfusion and High NIHSS Scores”	15
Breast Cancer Screening in Women With Multiple Sclerosis: A Mixed‐Methods Study	15
Catechol‐O‐methyltransferase inhibition with entacapone: Evidence from controlled clinical trials in Parkinson's disease	15
Impact of relative cerebral blood volume reduction on early neurological improvement in extensive ischemic stroke	15
Nerve Conduction Abnormalities Beyond Conduction Block in Multifocal Motor Neuropathy. Impact on Diagnostic Criteria Accuracy	15
Epilepsy Stands Nearby: A Pilot CT Perfusion Study on Post‐Stroke Non‐Convulsive Status Epilepticus	15
Prognostic Value of Cerebral Hemodynamics Assessment on 24‐h Transcranial Color‐Coded Doppler Following a Successful Thrombectomy	15
	15
Globus pallidus internus versus subthalamic nucleus deep brain stimulation for isolated dystonia: A 3‐year follow‐up	15
Early predictors of dysphagia in ischaemic stroke patients	15
Symposia	15
Chronic vestibular syndromes in the elderly: Presbyvestibulopathy—an isolated clinical entity?	14